Cadila Healthcare finalizes definitive agreement with Microbix

24 Aug 2012 Evaluate

Cadila Healthcare has finalized definitive agreement with Microbix regarding re-launch of Urokinase, a critical care therapy in North America. The company, earlier on January 6, 2012, had reached the agreement with Microbix to market Urokinase.

Cadila Healthcare focuses on various areas, such as formulations (human and veterinary), new drug discovery, novel drug delivery, pharmaceutical ingredients, analytical research, phytochemistry, biotechnology, plant tissue culture, etc.

Zydus Lifesciences Share Price

872.95 -8.15 (-0.92%)
20-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1381.00
Zydus Lifesciences 872.95
Lupin 2160.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×